[A "primitive" variant of the blast crisis in chronic myeloleukemia]. 1995

A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva

While immunotyping blast cells from 45 patients with CML blast crisis, we detected 5 cases with immunologically primitive blast cells. The immunological phenotype of these cells corresponded to that of primitive stem cells which are characterized by expression of CD34 and HLA-DR antigens in the absence of other immunological markers. We suggest that blast cells from these patients may undergo differentiation similar to that of primitive stem cells that implies the existence of a new immunological variant of CML blast crisis, a primitive variant. Morphologically, blast cells in 3 cases could be classified as myeloid, in 2 cases precise identification was impossible. Cytochemically, this type of cells can be defined as mixed. The patients with CD34+ phenotype do not differ clinically or hematologically from those with CML blast crisis. Blast cells with membrane marker CD34 are likely to arise in any CML phase either as a component of overall leukemic population or predominant, single subclone.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001752 Blast Crisis An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. Blast Phase,Blast Crises,Blast Phases,Crises, Blast,Crisis, Blast,Phase, Blast,Phases, Blast
D005260 Female Females
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias

Related Publications

A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
January 1990, Terapevticheskii arkhiv,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
April 1973, Problemy gematologii i perelivaniia krovi,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
July 1982, Problemy gematologii i perelivaniia krovi,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
January 1986, Terapevticheskii arkhiv,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
February 1980, Problemy gematologii i perelivaniia krovi,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
January 1990, Voprosy onkologii,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
April 1991, Vrachebnoe delo,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
January 1984, Eksperimental'naia onkologiia,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
October 1970, Problemy gematologii i perelivaniia krovi,
A Iu Baryshnikov, and A G Turkina, and I N Moiseenkova, and E A Frolova, and N P Sediakhina, and O A Diagileva, and N D Khoroshko, and R A Mokeeva
September 1979, Problemy gematologii i perelivaniia krovi,
Copied contents to your clipboard!